Paradigm Specialty Networks are uniquely positioned to offer comprehensive specialty care options, while reducing administrative burden and delivering measurable cost savings for clients.

The newest nonopioid drug to manage acute post-surgical pain is expected to impact the workers compensation industry, as it likely will cost more than generic drugs often used for pain…

Dr. Michael Choo, chief medical officer, workers compensation, with Paradigm, discusses the newest pain medication approved by the FDA and its possible use in workers compensation.

The workers’ compensation system is facing an epidemic of negative patient experiences and diminished outcomes for musculoskeletal (MSK) injuries.

The “What's Your Why? Portraits of Purpose” engagement activity at Paradigm’s booth, invited participants to share the driving force behind their work in the workers’ compensation industry.

With 30-plus years of catastrophic injury data, focused expertise, and proven outcomes, Paradigm works with clients to meet the evolving needs of their most volatile claims.

Blue Cross Blue Shield of Massachusetts and Paradigm together serve 3 million covered lives. Paradigm’s contract with Myomo represents its commitment to assessing and evaluating appropriateness of medical innovations like…